版本:
中国

BRIEF-Mylan receives CRL for generic Advair Diskus ANDA

March 29 Mylan NV:

* Mylan comments on generic Advair Diskus abbreviated new drug application

* In conjunction with Mylan's GDUFA goal date, company received a complete response letter from FDA regarding its ANDA for generic Advair Diskus

* Is in process of reviewing the response and will provide an update on its application as soon as practicable once it has completed its review Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐